Award
NIH Reporter #75N95022D00021-P00004-759502300001-1
Development of Enzyme-Linked Immunosorbent Assays (ELISAs) for NINDS NIH Blueprint Neurotherapeutics (BPN) Biologics Project
Recipient
Battelle Centers/Public Health Research & Evaluation
Award Amount
$136,760.00
Ceiling
$136,760.00
Awarded
February 07, 2023
Identifier
75N95022D00021-P00004-759502300001-1
Award for developing ELISA assays for neurological disorder therapeutics under NIH NINDS funding, awarded to Battelle Centers with an amount of $136,760.
Description
This project involves the development of ELISA assays for neurological disorder therapeutics, funded by the NIH NINDS, with a total award amount of $136,760, starting from February 7, 2023, and ending on February 6, 2028. The primary organization involved is Battelle Centers in Columbus, Ohio.